S tudies defining the course and outcome of people experiencing their FEP generally report an improvement in symptoms and functioning. 1 Specialized FEP programs typically treat clients from 18 to 36 months and then refer patients elsewhere. There are little data describing the next step in terms of where these FEP clients are followed at the end of their treatment in an FEP program. The Calgary EPP is a com-prehensive multi-element program that offers 3 years of treatment and follow-up to all patients. 2 In our cohort of 292 FEP patients, we have reported significant improvement in insight, depression, positive symptoms, and social functioning after 1 year, 3-5 improvement in substance misuse over 3 years, 6 and that duration of untreated psychosis predicts later outcome. 7 We have described the longitudinal role of W La Revue canadienne de psychiatrie, vol 54, no 9, septembre 2009 626 Objective: Studies defining the course and outcome of people experiencing their first episode psychosis (FEP) generally report an improvement in symptoms and functioning. Little is known about the follow-up arrangements offered to patients when their time in a FEP comes to an end.
cognitive functioning 8 and premorbid functioning, 9 as well as publishing details on referral sources 10 and diagnostic stability. 11 The purpose of this paper was to determine the outcome at the end of a 3-year FEP program and the follow-up care for people after discharge from a specialized FEP program.
Method

Subjects
During a 4-year period from January 1997 to December 2000, 292 people (197 men, 95 women) were admitted to the Calgary EPP who were experiencing their FEP. 2 The EPP serves an urban population of about 1 million and possibly includes most potential incidence cases. 12 These people presented to the EPP (67% as outpatients, 33% as inpatients) with their FEP. They had received no more than 3 months of previous adequate treatment. 13 Patients were excluded if they had a diagnosis of affective psychosis, or a history of neurological disorders, head injury, epilepsy, or did not speak English well enough to adequately complete the assessments. Patients with affective disorder were not included because program funding was not adequate for the additional staff that would be required. Most of the sample was single (86.3%), with a mean age of 24.5 years (SD 8.2), had completed grade 12 (60%), lived at home (77.1%), and was Caucasian (76.4%).
Diagnoses were conducted at the initial assessment and then repeated at 1 year. All subjects met DSM-IV criteria for a schizophrenia spectrum disorder or other psychotic disorder [14] [15] as assessed by the SCID-I for DSM-IV 15 ( Table 1) .
Measures
Measures include the PANSS, 16 the Calgary Depression Scale for Schizophrenia, 17 and the QLS. 18 The QLS has been widely used as a measure of functioning and more recently in FEP studies. 19 
Procedures
Formal consent was obtained from all patients. This outcome evaluation was approved by the local ethics committee at the University of Calgary. Diagnoses were obtained by the clinical research team of the EPP using the SCID and including all available sources of information. Diagnostic interviews occurred on admission to the program with additional information collected during the first month in the program. All raters for the SCID and the PANSS were experienced researcher-clinicians who used these measures in other research projects and demonstrated adequate reliability at regular intervals. Assessments were conducted at baseline, 12 months, 24 months, and 36 months.
Results
At 1 year, there were 196 completed assessments, with 163 at 2 years, and 147 at 3 years. On average, of patients not completing a follow-up assessment, 47% were dropouts, 37% moved away for legitimate reasons and were obtaining treatment elsewhere, and 16% were attending the program but failed to attend the assessment. Differences between patients who dropped out before baseline and those who remained in the program and completed at least the 1-year assessment were examined using Student t tests. There were no differences in demographics, QLS, depression, or positive symptoms. Patients who dropped out before the 1-year assessment had fewer negative symptoms (13.70, compared with 15.27, t = 2.1, df = 283, P < 0.05).
First, repeated measures analysis was used to determine the change during 3 years for symptoms and functioning with only patients who were present for all 3 assessments. There were significant improvements over time for positive symptoms (Wilks l = 0.42, P < 0.001), with most changes occurring in the first year (t = 11.51, df = 132, P < 0.001); for depression (Wilks l = 0.80, P < 0.001) with most changes occurring in the first year (t = 5.08, df = 131, P < 0.001); for social functioning as assessed by QLS (Wilks l = 0.42, P < 0.001) with changes occurring each year (t = 7.71, df = 125, P < 0.001, t = 2.52, df = 125, P = 0.01, t = 2.18, df = 125 P = 0.03), and no change for negative symptoms. As not all patients remained for 3 years, we also examined outcome with paired t tests using the last observation carried forward. There were significant improvements in depression (t = 4.52, df = 201, P < 0.001), positive symptoms (t = 13.0, df = 200, P < 0.001), and QLS (t = 9.65, df = 197, P < 0.001). There was no change in negative symptoms. Descriptive data from these comparisons are presented in Table 2 .
Many were discharged prior to the 3 years, with 56% remaining for the entire 3-year period. The reasons for discharge are presented in Table 3 . We also present in this table the places to which FEP patients were referred.
The criteria used for making follow-up recommendations included the need for case management services, insight, and stability. Patients were considered to need case management services if they were on disability, in supported housing, using rehabilitation services such as assisted employment, or in need of other specialized mental health services such as addiction treatment. Patients were considered stable if they had no admissions to hospital or emergency services in the last year of the program. Patients were referred to their family physician only if they were stable, were not receiving case management services, and were only receiving maintenance pharmacotherapy or no pharmacotherapy. Patients referred to psychiatrists' offices were not receiving case management services but were considered more symptomatic and in need of more active pharmacotherapeutic management. We then combined these groups into 4 categories: mental health programs, family physicians, private psychiatrists, and dropouts. We used 1-way analysis of variances to determine if there were differences in symptoms and functioning at discharge between these groups. The models were significant (P < 0.001) for positive symptoms (F = 15.25, df = 3,198), negative symptoms (F = 16.10, df = 3,198), and QLS (F = 30.33, df = 3,198), but not for depression. For each model, patients who were followed by their family physician had significantly lower ratings of positive and negative symptoms and improved QLS, compared with patients who were referred to specialized schizophrenia or other mental health programs, as well as those who dropped out.
Discussion
In our study, we report on the final outcome in terms of social and symptomatic functioning of a cohort of 292 FEP patients who had participated in a 3-year multi-element program. To our knowledge, this is the first naturalistic report of a large cohort of patients that have been followed with routine assessments throughout the course of a 3-year comprehensive multi-element specialized program for FEP patients. More than 50% remained for 3 years and 27% dropped out, disappeared, or refused to continue. Overall, by the time they left, patients had improved in depression, positive symptoms, and social functioning. No change was observed in negative symptoms. Despite the lack of improvement in negative symptoms, patients continued to improve in social functioning in the second and third years of the program.
Using explicit criteria to define need, we found that about 40% of patients went to specialized mental health services, 24% to family physicians for follow-up, and 27% were lost to follow-up. Although we have no formal information on the outcome of dropouts, those who relapsed and required admission would probably have been referred back to the program. Not surprisingly, patients who were followed by family physicians had the lowest levels of positive and negative symptoms and the highest levels of social functioning.
Strengths of our study were that this was a large sample that included most potential incidence cases as well as a wide W La Revue canadienne de psychiatrie, vol 54, no 9, septembre 2009 628 Brief Communication range of schizophrenia spectrum disorders as would be expected in a FEP sample. Further, our sample was a first presentation for treatment sample and not a first admission to hospital sample. Our assessments were broad, including symptoms, functioning, outcome, and cognition. Our study is limited in that it is not a randomized trial of outcome and there is no comparison group. There are dropouts in each of the assessment periods. However, 27% is an improvement on the 50% attendance rates reported for follow-up in a nonspecialized program. 20 In conclusion, most patients treated in an EPP will need follow-up, the largest group will require specialized mental health services in the community, but a significant group can be followed by family physicians. More work is needed to understand adherence rates and to improve on them if we want to further improve our care of FEP patients. 
Résumé : Résultat de trois ans de traitement dans un programme de psychose précoce
Objectif : Les études définissant l'évolution et le résultat des personnes qui vivent leur premier épisode psychotique rapportent généralement une amélioration des symptômes et du fonctionnement. Mais nous ne savons presque rien des arrangements de suivi offerts aux patients lorsque leur participation à un programme de premier épisode prend fin.
Méthode : Notre étude porte sur un échantillon de patients au premier épisode (n = 292) qui ont été suivis durant jusqu'à 3 ans dans un service de premier épisode spécialisé à éléments multiples.
Résultats : Une amélioration des symptômes positifs et du fonctionnement social, mais non des symptômes négatifs, a été observée dans cet échantillon, tant chez ceux qui ont terminé 3 ans dans le programme que chez ceux qui ont quitté tôt. Quelque 40 % ont été adressés à des services spécialisés de santé mentale, alors que 24 % ont été suivis par leur médecin de famille. Les patients qui étaient suivis par des médecins de famille avaient une diminution des symptômes et une amélioration du fonctionnement.
Conclusion :
La plupart des patients traités dans un programme de psychose précoce auront besoin d'un suivi, le groupe le plus nombreux nécessitera des services spécialisés communautaires de santé mentale, mais un groupe significatif peut être suivi par des médecins de famille.
